Meridian Bioscience ROA 2006-2019 | VIVO

Current and historical return on assets (ROA) values for Meridian Bioscience (VIVO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Meridian Bioscience ROA for the three months ending June 30, 2019 was 11.97%.
Meridian Bioscience ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $0.03B $0.32B 9.29%
2019-03-31 $0.03B $0.25B 10.70%
2018-12-31 $0.03B $0.25B 9.90%
2018-09-30 $0.02B $0.25B 9.09%
2018-06-30 $0.02B $0.25B 9.50%
2018-03-31 $0.02B $0.26B 6.79%
2017-12-31 $0.02B $0.25B 8.41%
2017-09-30 $0.02B $0.25B 8.43%
2017-06-30 $0.02B $0.25B 8.01%
2017-03-31 $0.03B $0.25B 11.50%
2016-12-31 $0.03B $0.25B 11.43%
2016-09-30 $0.03B $0.25B 13.46%
2016-06-30 $0.04B $0.26B 15.87%
2016-03-31 $0.04B $0.26B 17.37%
2015-12-31 $0.04B $0.19B 19.83%
2015-09-30 $0.04B $0.18B 19.53%
2015-06-30 $0.04B $0.18B 19.69%
2015-03-31 $0.04B $0.18B 19.69%
2014-12-31 $0.04B $0.18B 19.69%
2014-09-30 $0.03B $0.18B 19.18%
2014-06-30 $0.04B $0.18B 19.75%
2014-03-31 $0.04B $0.18B 20.54%
2013-12-31 $0.04B $0.18B 20.90%
2013-09-30 $0.04B $0.18B 22.06%
2013-06-30 $0.04B $0.17B 22.60%
2013-03-31 $0.04B $0.17B 22.40%
2012-12-31 $0.04B $0.16B 22.68%
2012-09-30 $0.04B $0.16B 22.12%
2012-06-30 $0.03B $0.16B 21.05%
2012-03-31 $0.03B $0.16B 19.81%
2011-12-31 $0.03B $0.16B 17.92%
2011-09-30 $0.03B $0.16B 17.25%
2011-06-30 $0.03B $0.16B 15.97%
2011-03-31 $0.02B $0.16B 15.56%
2010-12-31 $0.02B $0.16B 15.03%
2010-09-30 $0.03B $0.16B 17.02%
2010-06-30 $0.03B $0.15B 19.61%
2010-03-31 $0.03B $0.15B 21.60%
2009-12-31 $0.03B $0.16B 22.48%
2009-09-30 $0.03B $0.16B 22.15%
2009-06-30 $0.03B $0.15B 21.84%
2009-03-31 $0.03B $0.15B 21.42%
2008-12-31 $0.03B $0.15B 21.60%
2008-09-30 $0.03B $0.15B 21.31%
2008-06-30 $0.03B $0.14B 20.36%
2008-03-31 $0.03B $0.14B 21.68%
2007-12-31 $0.03B $0.14B 21.71%
2007-09-30 $0.03B $0.13B 21.47%
2007-06-30 $0.03B $0.13B 21.18%
2007-03-31 $0.02B $0.12B 18.33%
2006-12-31 $0.02B $0.12B 17.95%
2006-09-30 $0.02B $0.12B 16.63%
2006-06-30 $0.02B $0.12B 16.11%
2006-03-31 $0.02B $0.11B 15.50%
2005-12-31 $0.01B $0.11B 14.62%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.422B $0.214B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 28.00
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Boston Scientific (BSX) United States $58.240B 28.25
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
ResMed (RMD) United States $18.992B 36.22
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
NuVasive (NUVA) United States $3.380B 26.95
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Omeros (OMER) United States $0.915B 0.00
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
United-Guardian (UG) United States $0.088B 20.72
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00